Compare CRL & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRL | BIO |
|---|---|---|
| Founded | 1947 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 8.7B |
| IPO Year | 2000 | N/A |
| Metric | CRL | BIO |
|---|---|---|
| Price | $226.47 | $312.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 4 |
| Target Price | $203.58 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 679.5K | 184.0K |
| Earning Date | 02-18-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,023,704,000.00 | $2,557,500,000.00 |
| Revenue This Year | N/A | $1.62 |
| Revenue Next Year | $1.70 | $2.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $91.86 | $211.43 |
| 52 Week High | $228.88 | $373.69 |
| Indicator | CRL | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 70.58 | 47.12 |
| Support Level | $216.03 | $306.52 |
| Resistance Level | $227.51 | $328.56 |
| Average True Range (ATR) | 7.73 | 9.16 |
| MACD | 0.14 | -0.38 |
| Stochastic Oscillator | 91.22 | 40.11 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.